» Articles » PMID: 38419908

Device and Surgical Procedure-related Infections in Canadian Acute Care Hospitals, 2017-2021

Overview
Date 2024 Feb 29
PMID 38419908
Affiliations
Soon will be listed here.
Abstract

Background: Healthcare-associated infections (HAIs) are a significant healthcare burden in Canada. National surveillance of HAIs at sentinel acute care hospitals is conducted by the Canadian Nosocomial Infection Surveillance Program. This article describes device and surgical procedure-related HAI epidemiology in Canada from 2017 to 2021.

Methods: Data were collected from over 60 Canadian sentinel acute care hospitals between January 1, 2017, and December 31, 2021, for central line-associated bloodstream infections (CLABSIs), hip and knee surgical site infections (SSIs), cerebrospinal fluid shunt SSIs and paediatric cardiac SSIs. Case counts, rates, patient and hospital characteristics, pathogen distributions and antimicrobial resistance data are presented.

Results: Between 2017 and 2021, 2,898 device and surgical procedure-related infections were reported, with CLABSIs in intensive care units representing 69% (n=2,002) of all reported infections under surveillance. Significant rate increases were observed in adult mixed intensive care unit CLABSIs (1.08-2.11 infections per 1,000 line days, =0.014) while decreases were observed in SSIs following knee arthroplasty (0.34-0.27 infections per 100 surgeries, =0.05). No changes in trends were observed in the other reported HAIs. Of the 3,089 pathogens identified, the majority were gram-positive (66%), followed by gram negative (23%) and fungi (11%). Coagulase-negative staphylococci (22%) and (17%) were the most frequently isolated pathogens.

Conclusion: Epidemiological and microbiological trends among select device and surgical procedure-related HAIs are essential for benchmarking infection rates nationally and internationally, identifying any changes in infection rates or antimicrobial resistance patterns and helping inform hospital infection prevention and control and antimicrobial stewardship policies and programs.

Citing Articles

The adoption and compliance to central line-associated bloodstream infection insertion and maintenance bundle programs in intensive care unit settings across Canada.

Zhou Z, Silva A, Cannon K, Chow B, Comeau J, Ellis C Infect Control Hosp Epidemiol. 2024; :1-4.

PMID: 39696922 PMC: 11790321. DOI: 10.1017/ice.2024.189.

References
1.
Rosenthal V, Duszynska W, Ider B, Gurskis V, Al-Ruzzieh M, Myatra S . International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013-2018, Adult and Pediatric Units, Device-associated Module. Am J Infect Control. 2021; 49(10):1267-1274. DOI: 10.1016/j.ajic.2021.04.077. View

2.
Langley J, Gravel D, Moore D, Matlow A, Embree J, MacKinnon-Cameron D . Study of cerebrospinal fluid shunt-associated infections in the first year following placement, by the Canadian Nosocomial Infection Surveillance Program. Infect Control Hosp Epidemiol. 2009; 30(3):285-8. DOI: 10.1086/593969. View

3.
Springer B, Cahue S, Etkin C, Lewallen D, McGrory B . Infection burden in total hip and knee arthroplasties: an international registry-based perspective. Arthroplast Today. 2017; 3(2):137-140. PMC: 5485227. DOI: 10.1016/j.artd.2017.05.003. View

4.
. Device and surgical procedure-related infections in Canadian acute care hospitals from 2011 to 2020. Can Commun Dis Rep. 2023; 48(7-8):325-339. PMC: 10278973. DOI: 10.14745/ccdr.v48i78a04. View

5.
Simon T, Butler J, Whitlock K, Browd S, Holubkov R, Kestle J . Risk factors for first cerebrospinal fluid shunt infection: findings from a multi-center prospective cohort study. J Pediatr. 2014; 164(6):1462-8.e2. PMC: 4035376. DOI: 10.1016/j.jpeds.2014.02.013. View